Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.
Joshua Zeichner, MD: Here’s case No. 1. This is a 2-year-old boy previously diagnosed with moderate atopic dermatitis. He presents to his dermatologist with worsening of red, dry, itchy patches on his arms. The family has taken the child to the pediatrician, who recommended over-the-counter agents. The irritation and redness improved initially, but after 3 months, the patient experienced a flare. The family was then referred to the dermatologist for the next steps.
Transcript edited for clarity
Dupilumab safe, effective for up to 1 year for atopic dermatitis in infants, preschool children
May 3rd 2024According to new study data presented at the 2024 Pediatric Academic Societies Meeting, dupilumab (dupixent; Sanofi and Regeneron) demonstrated positive safety and efficacy results for up to 1 year in infants and preschool-age children with atopic dermatitis.
Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin of color
March 8th 2024Data from a pair of identical, phase 3, double-blind, randomized, and vehicle-controlled trials were presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California.